What is the equivalent dose of Estrogel (estradiol) for Evorel 75 (estradiol) half a patch?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Estradiol Patch to Gel Conversion

Half of an Evorel 75 patch (37.5 mcg/day) converts to approximately 0.5-0.75 mg of Estrogel daily.

Conversion Rationale

The Evorel 75 patch delivers 75 mcg of estradiol per 24 hours, so half a patch provides approximately 37.5 mcg/day 1. Standard transdermal patches releasing 50 mcg/24 hours are considered equivalent to 0.5-1 mg of transdermal gel daily 2, 1. Using proportional dosing, half of a 75 mcg patch (37.5 mcg) would correspond to approximately 0.5-0.75 mg of Estrogel.

Specific Dosing Recommendation

  • Start with 0.5 mg Estrogel daily as the most conservative equivalent dose 1
  • If symptoms persist after 2-3 months, increase to 0.75 mg daily 1
  • The typical dose range for transdermal gel is 0.5-1 mg daily, which achieves plasma estradiol levels of 35-100 pg/ml 3

Application Instructions

  • Apply Estrogel to clean, dry skin on the lower abdomen, upper outer arm, or thighs 1
  • Allow gel to dry completely before dressing (typically 2-5 minutes) 4
  • Rotate application sites to minimize skin irritation 1

Critical Endometrial Protection

If you have an intact uterus, you must add progestin supplementation to prevent endometrial hyperplasia and cancer 2, 1:

  • Micronized progesterone 200 mg orally or vaginally for 12-14 days every 28 days (first-line choice) 2, 5
  • Alternative: Medroxyprogesterone acetate 10 mg daily for 12-14 days per month 2, 5
  • Alternative: Dydrogesterone 10 mg daily for 12-14 days per month 2

Monitoring and Titration

  • Assess symptom control after 2-3 months on the initial dose 1
  • Plasma estradiol levels should reach 35-55 pg/ml minimum for efficacy 3
  • If vasomotor symptoms persist, increase gel dose incrementally by 0.25 mg 4

Common Pitfall to Avoid

Do not assume direct mcg-to-mg conversion between patches and gels. While both are transdermal, gels have different absorption kinetics and surface area requirements compared to patches 4, 6. The gel requires a higher nominal dose (in mg) to achieve similar plasma levels as patches (in mcg/day) due to differences in delivery systems 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.